Hib-EuroSud'95: the South exists.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Vaccine

• Publication date

  1996-12-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0264-410X(96)00169-7PMID 9032883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France.

  1996cited by this paper
• Haemophilus influenzae vaccines for infants in Spain

  1995cited by this paper
• Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, Spain.

  1995cited by this paper
• The impact of conjugate vaccine on carriage of Haemophilus influenzae type b.

  1995cited by this paper
• Efficacy of Hib vaccine

  1994cited by this paper
• Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen.

  1994cited by this paper
• Antibiotic resistance of microorganisms involved in ear, nose and throat infections

  1994cited by this paper
• Preventing Haemophilus influenzae meningitis: Germany's experience.

  1994cited by this paper
• Efficacy of Hib vaccine.

  1994cited by this paper
• Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T.

  1994cited by this paper
• Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands.

  1994cited by this paper
• Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands

  1994cited by this paper
• Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991.

  1993cited by this paper
• Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.

  1993cited by this paper
• Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine.

  1993cited by this paper
• Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91).

  1993cited by this paper
• Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination.

  1993cited by this paper
• Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group.

  1993cited by this paper
• Bacterial infections of humans: epidemiology and control.

  1993cited by this paper
• Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis?

  1992cited by this paper
• Targets of the (β-Lactam Antibiotics, Penicillin-Binding Proteins, in Ampicillin-Resistant, Non-β-Lactamase-Producing Haemophilus influenzae

  1992cited by this paper
• Pathophysiology of blood-brain barrier alterations during experimental Haemophilus influenzae meningitis.

  1992cited by this paper
• Bacterial meningitis: pathogenesis, pathophysiology, and progress.

  1992cited by this paper
• Targets of the beta-lactam antibiotics, penicillin-binding proteins, in ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae.

  1992cited by this paper
• Epidemiology of invasive Haemophilus influenzae type b disease.

  1992cited by this paper
• Haemophilus influenzae Type b

  1991cited by this paper
• The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

  1991cited by this paper
• Antibiotic resistance inHaemophilus influenzae: mechanisms, clinical importance and consequences for therapy

  1991cited by this paper
• The epidemiology and prevention of disease caused by Haemophilus influenzae type b.

  1991cited by this paper
• The second European collaborative study on the frequency of antimicrobial resistance inHaemophilus influenzae

  1990cited by this paper
• Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications.

  1990cited by this paper
• Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.

  1990cited by this paper
• Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone.

  1989cited by this paper
• Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials.

  1988cited by this paper
• Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation.

  1988cited by this paper
• National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae

  1988cited by this paper
• Multiply resistant Haemophilus influenzae type b causing meningitis: comparative clinical and laboratory study.

  1986cited by this paper
• Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria.

  1975cited by this paper

• Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.

  2004cites this paper
• Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain.

  2001cites this paper
• Immune responses to administration of a vaccine against Haemophilus influenzae type B in splenectomized and non-splenectomized patients.

  1999cites this paper
• National Surveillance System and Hib meningitis incidence in Italy

  1999cites this paper
• Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age.

  1998cites this paper
• Haemophilus influenzae type b disease and vaccination in Europe: lessons learned.

  1998cites this paper